As part of the Year 4 & 5 funding settlement for community pharmacy, it was agreed that a new Flat Fee payment would be introduced from April 2023. This would be paid to all contractors who dispense at least 101 items a month, up to a national total of £70m on an annual basis. See
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Progynova® TS) 100micrograms/24hours transdermal patches. MSN/2023/035 Tier 2 – medium impact Date of issue 28th March 2023 Estradiol (Progynova® TS) 100microgram/24hours patches are out of stock until w/c 5th June 2023. An alternative brand of estradiol patches, FemSeven®, of the
Read moreThe Drug Tariff for April 2023 will contain changes to the discount deduction arrangements for pharmacy contractors, including changes which PSNC rejected, and are subsequently being imposed. The changes being implemented from 1 April include: All concession lines to be considered as Group Items for Discount Not Deducted i.e. DND or zero discount (ZD) items
Read moreIn response to a significant ongoing disruption to the supply of Progynova® TS 100micrograms/24hours transdermal patches, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today, 28 March 2023, SSP052 provides that for every Progynova® TS 100micrograms/24hours transdermal patch originally prescribed, one FemSeven® 100 patch must be supplied. SSP052,
Read moreThe NHS Business Services Authority (NHSBSA) has updated their antibiotic review spreadsheet for the Pharmacy Quality Scheme (PQS) 2022/23. As part of the Prevention domain, contractors are required to carry out a TARGET leaflet review (further details of the requirements can be found on the PSNC PQS hub page under the ‘Domain 4 – Prevention’
Read more7,410 contractors have submitted their valproate audit data; have you submitted your data yet? By 31st March 2023, all community pharmacy contractors must have completed the 2022/23 national clinical audit on valproate over a six-week consecutive period and have submitted their data via the Valproate audit 2022/23 tab on MYS. This is a mandatory contractual
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Acetazolamide (Diamox® SR) 250mg modified-release capsules. MSN/2023/033 Tier 2 – medium impact Date of issue 27th March 2023 Acetazolamide (Diamox® SR) 250mg modified-release capsules are out of stock until end of July 2023. Acetazolamide immediate release 250mg tablets remain available and
Read moreThe NHS Business Services Authority (NHSBSA) has updated its spreadsheet showing which community pharmacy contractors have made a referral to the NHS Digital Weight Management Programme (DWMP) as part of the Pharmacy Quality Scheme (PQS) 2022/23. To gain the maximum number of points and to meet the Referral stage of the Healthy living support domain,
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/2.5mg tablets. MSN/2023/034 Tier 2 – medium impact Date of issue 27th March 2023 Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/2.5mg tablets is out of stock until w/c 26th June 2023. Alternative continuous combined hormone replacement therapies (HRT) containing
Read morePSNC has published a roundup of the quarterly meeting of the Community Pharmacy IT Group (CP ITG) that was held during March 2023 and pharmacy IT developments. This IT bulletin includes updates on: Considerations regarding current pharmacy IT prioritisation Updates on the National Care Records Service (NCRS) portal which will replace the Summary Care Record
Read more
